Skip to product information
1 of 1

HealthCert Education

Chemoprevention in skin cancer medicine

Chemoprevention in skin cancer medicine

"Chemoprevention in Skin Cancer Medicine" is a specialised course designed for healthcare professionals seeking to enhance their knowledge of preventative strategies against skin cancer. This comprehensive course explores the use of chemopreventive agents, including retinoids, NSAIDs, nicotinamide, and sunscreens, and their role in reducing the risk of melanoma and keratinocytic skin cancers. Participants will learn evidence-based approaches, supported by clinical data and dermoscopic imagery, to develop effective prevention plans for high-risk populations. Delivered by a leading expert, this course equips practitioners with the tools to mitigate skin cancer risks and improve patient outcomes.

time-icon 4.0 hrs EA | 6.0 hrs RP | 0.0 hrs OM
Regular price $195.00
Regular price Sale price $195.00
Sale Sold out

SKU:SHOP-D4MED

View full details
  • FLEXIBLE TIMING

  • 100% ONLINE

  • accredited Course

  • Expert instructor

Chemoprevention in Skin Cancer Medicine delves into the principles and applications of chemoprevention to combat skin cancer, providing evidence-based strategies and practical insights for healthcare professionals.

The course introduces the fundamentals of chemoprevention, which involves using agents to prevent, delay, or reduce the recurrence of cancer. Participants will explore:
- Types of Chemoprevention: Differentiating between primary, secondary, and tertiary chemoprevention, and their application in varying stages of cancer development.
- Mechanisms of Action: Insights into blocking and suppressing agents that inhibit carcinogen uptake, induce cell apoptosis, or reduce cell proliferation.
- Agents in Focus:
- Sunscreens: Their role as topical blocking agents and an analysis of evidence on their efficacy in preventing melanoma and actinic keratosis.
- Retinoids: Evaluating the effectiveness of topical and systemic retinoids in reducing keratinocytic cancers.
- Nicotinamide: Promising results in reducing actinic keratosis and squamous cell carcinoma, supported by recent phase III clinical trials.
- NSAIDs and Statins: Examining their potential roles and limitations in skin cancer prevention based on current studies.
- Dermoscopic Insights: Understanding precancerous lesions such as actinic keratosis and their progression to invasive carcinomas, aided by clinical and dermoscopic imagery.
- Population-Specific Approaches: Strategies tailored for high-risk groups, such as individuals with genetic predispositions or extensive UV exposure.

This unit empowers practitioners with actionable knowledge to recommend and implement chemopreventive measures effectively. Through expert-led insights and interactive case discussions, participants will develop the skills needed to integrate chemoprevention into clinical practice, enhancing early intervention and reducing the burden of skin cancer.

  1. Determine use of chemoprevention and how it works in the fight against skin cancer.

All degree qualified medical practitioners.

cpd hours image

CPD Hours:

  • Education hours:  4.0
  • Reviewing performance hours: 6.0
  • Measuring outcome hours:  0.0
cpd hours image

Accreditations:

Royal Australian College of General Practice (RACGP) #407608

Australian College of Rural and Remote Medicine (ACRRM) #28099

cpd hours image

Study Mode:

100% online

cpd hours image

Study duration:

10.0 hrs self-paced

cpd hours image

ABOUT THE PRESENTER

Professor Harald Kittler

This course is presented by Professor Harald Kittler: MD.

He is the professor at the Department of Dermatology, Medical University of Vienna, Austria. He has special clinical interest in dermoscopy of pigmented skin lesions. His main research interest is digital dermoscopy, follow-up of pigmented skin lesions, and computer assisted digital dermoscopy. Harald has been working for over 10 years in the field of dermoscopy and has published a number of scientific articles especially in the field of digital dermoscopy and dermoscopic follow-up of melanocytic nevi.